Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Antineoplastics and mucositis: clinical and economic cost high

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Antineoplastics and mucositis: clinical and economic cost high. Pharmacoecon. Outcomes News 438, 5 (2003). https://doi.org/10.1007/BF03277023

    Download citation

    Keywords

    • Lymphoma
    • Neutropenia
    • Thrombocytopenia
    • Outcome News
    • Parenteral Nutrition